These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 917918)

  • 21. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
    Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
    Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of verampamil in the treatment of patients with chronic coronary insufficiency].
    Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA; Dubinina LT
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1478+. PubMed ID: 5536558
    [No Abstract]   [Full Text] [Related]  

  • 23. [Calcium antagonists and primary prevention of coronary disease].
    Rehnqvist N
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():13-6. PubMed ID: 7503620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
    Savvateev KL; Shinbaeva NA; Vygodin VA; Nikolenko SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):64-70. PubMed ID: 7259869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 26. [Multicenter long-term study of gallopamil in patients with coronary heart disease].
    Sućić M; Schiemann J
    Arzneimittelforschung; 1984; 34(11):1587-94. PubMed ID: 6543136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibility of developing tolerance to the antianginal effect of verapamil].
    Shakarova SSh; Martsevich SIu; Metelitsa VI; Vygodin VA; Strel'tsov AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):75-8. PubMed ID: 6508932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of verapamil and its N-dealkylated metabolites in patients with chronic ischemic heart disease undergoing long-term monotherapy].
    Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI; Riabokon' OS; Kokurina EV
    Farmakol Toksikol; 1988; 51(1):66-70. PubMed ID: 3360112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
    Reiterer W
    Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of coronary disease patients with Verapamil (Isoptin)].
    Buttolo R; Nardoni A
    Minerva Cardioangiol; 1972 Jan; 20(1):7-21. PubMed ID: 4258309
    [No Abstract]   [Full Text] [Related]  

  • 33. [The role of calcium antagonists in the treatment of arrhythmias in myocardial ischemia].
    Sannino A; Calabretta G; Raddi G; Santamaria G; Russo C
    Minerva Med; 1980 Mar; 71(8):597-8. PubMed ID: 7360390
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of verapamil in suppositories for treating patients with ischemic heart disease].
    Shkliar MB; Soleĭko MB; Alekseeva IP; Kul'chevich LV
    Vrach Delo; 1990 Aug; (8):13-5. PubMed ID: 2256273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Verapamil for regulation of cardiac rhythm disorders. Experience with our own patients].
    Arsov D; Serafimova E
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1290+. PubMed ID: 4098330
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. A randomized trial.
    Williams DB; Misbach GA; Kruse AP; Ivey TD
    J Thorac Cardiovasc Surg; 1985 Oct; 90(4):592-6. PubMed ID: 3900590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
    Fugit MD; Rubal BJ; Donovan DJ
    J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of verapamil in patients with asymptomatic stress-induced ischemia.
    Zilberman A; Rogel S
    Arch Intern Med; 1989 May; 149(5):1062-4. PubMed ID: 2719499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
    Reinfrank J; Eckardt A; Hahn KJ
    Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.